Matches in Wikidata for { <http://www.wikidata.org/entity/Q80215475> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- Q80215475 description "artículu científicu espublizáu n'abril de 2007" @default.
- Q80215475 description "im April 2007 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80215475 description "scientific article published on 26 April 2007" @default.
- Q80215475 description "wetenschappelijk artikel" @default.
- Q80215475 description "наукова стаття, опублікована у квітні 2007" @default.
- Q80215475 name "Phase I dose escalation and pharmacokinetic study of AZD2171, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinase, in patients with hormone refractory prostate cancer (HRPC)" @default.
- Q80215475 name "Phase I dose escalation and pharmacokinetic study of AZD2171, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinase, in patients with hormone refractory prostate cancer (HRPC)" @default.
- Q80215475 type Item @default.
- Q80215475 label "Phase I dose escalation and pharmacokinetic study of AZD2171, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinase, in patients with hormone refractory prostate cancer (HRPC)" @default.
- Q80215475 label "Phase I dose escalation and pharmacokinetic study of AZD2171, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinase, in patients with hormone refractory prostate cancer (HRPC)" @default.
- Q80215475 prefLabel "Phase I dose escalation and pharmacokinetic study of AZD2171, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinase, in patients with hormone refractory prostate cancer (HRPC)" @default.
- Q80215475 prefLabel "Phase I dose escalation and pharmacokinetic study of AZD2171, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinase, in patients with hormone refractory prostate cancer (HRPC)" @default.
- Q80215475 P1433 Q80215475-03125403-51A8-45A5-8903-EB698967AA71 @default.
- Q80215475 P1476 Q80215475-5B2EB000-A97E-469A-A784-3E53FC12C4F1 @default.
- Q80215475 P2093 Q80215475-1757C8BD-EDA3-4DCE-80CC-3E6D4CC1C2D6 @default.
- Q80215475 P2093 Q80215475-58BB8559-81F7-40F1-94FD-0381BF37F353 @default.
- Q80215475 P2093 Q80215475-71DD8651-E33C-421A-AABD-84762C42BBE2 @default.
- Q80215475 P2093 Q80215475-89F69949-C014-42B7-ADC8-F219219AB54B @default.
- Q80215475 P2093 Q80215475-E25A2259-6868-43F8-821B-641EBD6F4392 @default.
- Q80215475 P2093 Q80215475-E38230EE-71E0-41D7-90E8-7FAACDEDBA70 @default.
- Q80215475 P2093 Q80215475-F62AE91C-3375-47B9-916D-DBFF4C9BAB31 @default.
- Q80215475 P2093 Q80215475-F9CC247F-9109-4507-A292-A675C2EC2213 @default.
- Q80215475 P2860 Q80215475-1BFC1569-588D-413B-A145-F7CD7BD2E95D @default.
- Q80215475 P2860 Q80215475-232EF5C7-1674-4EAC-898C-1018B61D30F3 @default.
- Q80215475 P2860 Q80215475-27815087-CEF6-4EA3-A407-A37AFC40781A @default.
- Q80215475 P2860 Q80215475-2AE903B5-FFF2-45B7-8E3C-663BCF7410C4 @default.
- Q80215475 P2860 Q80215475-73CDB996-0D5D-4AFD-A86E-6A131274C222 @default.
- Q80215475 P2860 Q80215475-9558E977-46CF-4D34-954E-802DC8957D8E @default.
- Q80215475 P2860 Q80215475-97EBAAF5-3FFB-4B34-B1EE-33885F27B7B6 @default.
- Q80215475 P2860 Q80215475-9BB720B0-8606-40B1-BD85-D347ADD9C19C @default.
- Q80215475 P2860 Q80215475-CBB3D7CB-D036-420E-81A5-509E8B0DD177 @default.
- Q80215475 P2860 Q80215475-D261093D-DF2C-49E1-B480-518BC9FFFDC2 @default.
- Q80215475 P2888 Q80215475-D81203F2-16EC-4963-8578-15206353DDBD @default.
- Q80215475 P304 Q80215475-6B4CABEB-9797-474B-8BB2-7F7D35C1CE3B @default.
- Q80215475 P31 Q80215475-C5C87C71-D674-4D16-AC49-BF1DFFC2A710 @default.
- Q80215475 P356 Q80215475-8B9BA924-C729-4CD6-8FC4-0AD3FB219255 @default.
- Q80215475 P433 Q80215475-04E62B71-2D07-45BA-A790-A9E1E41F4D0E @default.
- Q80215475 P478 Q80215475-73CFB7F5-4283-44E6-99BE-5B4D67EC57A6 @default.
- Q80215475 P577 Q80215475-6ADC5929-7DAD-4238-827C-61A59CD93905 @default.
- Q80215475 P6179 Q80215475-DAED0065-9FA8-4D8D-AF77-7D788FFB8E35 @default.
- Q80215475 P698 Q80215475-610C771F-5F48-4692-9591-968CB3A470AB @default.
- Q80215475 P921 Q80215475-243CA978-8766-40A7-BD2F-41A88EBA4281 @default.
- Q80215475 P921 Q80215475-C4012149-D0B5-42CC-9B02-E8E990BF011E @default.
- Q80215475 P356 S10637-007-9050-Y @default.
- Q80215475 P698 17458505 @default.
- Q80215475 P1433 Q2312231 @default.
- Q80215475 P1476 "Phase I dose escalation and pharmacokinetic study of AZD2171, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinase, in patients with hormone refractory prostate cancer (HRPC)" @default.
- Q80215475 P2093 "Bruce Roth" @default.
- Q80215475 P2093 "Charles J Ryan" @default.
- Q80215475 P2093 "Charles Morris" @default.
- Q80215475 P2093 "Douglass Hutcheon" @default.
- Q80215475 P2093 "Eric J Small" @default.
- Q80215475 P2093 "Shauna Conry" @default.
- Q80215475 P2093 "Thomas Puchalski" @default.
- Q80215475 P2093 "Walter M Stadler" @default.
- Q80215475 P2860 Q28251373 @default.
- Q80215475 P2860 Q33767866 @default.
- Q80215475 P2860 Q34354300 @default.
- Q80215475 P2860 Q35182963 @default.
- Q80215475 P2860 Q35833169 @default.
- Q80215475 P2860 Q40582001 @default.
- Q80215475 P2860 Q43566256 @default.
- Q80215475 P2860 Q43670874 @default.
- Q80215475 P2860 Q72070762 @default.
- Q80215475 P2860 Q73715181 @default.
- Q80215475 P2888 s10637-007-9050-y @default.
- Q80215475 P304 "445-451" @default.
- Q80215475 P31 Q13442814 @default.
- Q80215475 P356 "10.1007/S10637-007-9050-Y" @default.
- Q80215475 P433 "5" @default.
- Q80215475 P478 "25" @default.
- Q80215475 P577 "2007-04-26T00:00:00Z" @default.
- Q80215475 P6179 "1050677478" @default.
- Q80215475 P698 "17458505" @default.
- Q80215475 P921 Q181257 @default.
- Q80215475 P921 Q323936 @default.